Paediatric palliative care and intellectual disability-A unique context

Jacqueline K Duc1,2,3, Anthony Robert Herbert1,2,3, Helen S Heussler1,3,4

  • 1Paediatric Palliative Care Service, Children's Health Queensland, Australia.

Insights

Caring for children with intellectual disability and life-limiting conditions requires a specialized approach. A child- and family-centered strategy is essential for best-practice paediatric palliative care.

Area of Science:

  • Paediatric Palliative Care
  • Intellectual Disability Research
  • Life-Limiting Conditions

Background:

  • Paediatric palliative care presents unique challenges for children with intellectual disability.
  • Limited research currently guides clinical practice in this complex area.
  • Addressing the intersection of intellectual disability and life-limiting conditions is crucial.

Purpose of the Study:

  • To describe the complex care needs of children with life-limiting conditions and intellectual disability.
  • To provide a best-practice guide for clinicians in this specialized field.
  • To synthesize existing literature and expert consensus.

Main Methods:

  • Literature synthesis and commentary.
  • Expert consensus from paediatric palliative care, oncology, and adult intellectual disability fields.
  • Identification of common clinical challenges.

Main Results:

  • Few studies specifically address palliative care for children with intellectual disability.
  • Common clinical challenges in day-to-day care were identified.
  • Expert insights were drawn from related literature.

Conclusions:

  • A longitudinal, child- and family-centered approach is paramount for optimal care.
  • Significant gaps in research necessitate urgent investigation.
  • Best-practice care requires tailored strategies for this population.
Abstract

Related Concept Videos

Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
838
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
2.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
303
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276